Epitope Mapping of Bovine Leukemia Virus Transactivator Protein Tax

Journal of Veterinary Medical Science

Volumn 60, Issue 5, 1998, Pages 599-605

  Sakakibara, Nobuhiro ^a   Kabeya, Hidenori ^a   Ohashi, Kazuhiko ^a   Sugimoto, Chihiro ^a   Onuma, Misao ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bovine leukemia virus; Epitope mapping; Transactivator protein

Indexed keywords

BOVINAE; BOVINE LEUKEMIA VIRUS;

EPITOPE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; TAX PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BOVINE LEUKEMIA VIRUS; C57BL MOUSE; CATTLE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; GENE PRODUCTS, TAX; LEUKEMIA VIRUS, BOVINE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 0032060506     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.60.599     Document Type: Article

References (31)

1. Altaner, C., Ban, J., Altanerova. V. and Janik, V. 1991. Protective vaccination against bovine teukaemia virus infection by means of cell-derived vaccine. Vaccine 9: 889-895.
2. Bruck, C., Mathot, S., Portetelle, D., Berte. C., Franssen, J.D., Herion, P and Burny, A. 1982. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51. Virology 122: 342-352.
3. Callebaut, I., Portetelle, D., Burny, A. and Mornon, J.P. 1994. Identification of functional sites on bovine leukemia virus envelope glycoproteins using structural and immunological data. Eur. J. Biochem. 222: 405-414.
4. Callebaut, I., Voneche, V., Mager, A., Fumiere, O., Krchnak, V., Merza, M., Zavada, J., Mammerickx, M., Burny, A. and Portetelle, D. 1993. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51. J. Virol. 67: 5321-5327.
5. Clerici, M., Lucey, D., Zajac, R., Boswell, R., Gebel, H., Takahshi, H., Berzofsky, J. and Shearer, G. 1991. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J. Immunol. 146: 2214-2219.
6. Gatei, M.H., Good, M.F., Daniel, R.C. and Lavin, M.F. 1993. T-cell responses to highly conserved CD4 and CDS epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development. J. Virol. 67: 1796-1802.
7. Gatei, M.H., Naif, H.M., Kumar, S., Boyle, D.B., Daniel, R.C., Good, M.F. and Lavin, M.F. 1993. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70. J. Virol. 67: 1803-1810.
8. Haraguchi, S., Good, R.A. and Day, N.K. 1995. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today 16: 595-603.
9. Hollsberg, P., Weber, W.E., Dangond, F., Batra, V., Sette, A. and Hafler, D.A. 1995. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. U.S.A. 92: 4036-4040.
10. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182: 1579-1584.
11. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (Lond.) 348: 245-248.
12. Kabeya, H., Ohashi, K., Ohishi, K., Sugimoto, T., Amanuma, H. and Onuma, M. 1996. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep. Vaccine 14: 1118-1122.
13. + cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 3: 761-767.
14. Kannagi, M., Shida, H., Igarashi, H., Kuruma, K., Murai, H., Aono, Y., Maruyama. I., Osame, M., Hattori, T., Inoko, H. and Harada, S. 1992. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 66: 2928-2933.
15. Kettmann, R., Burny, A., Callebaut, I., Droogmans, L., Mammerickx. M., Willems, L. and Portetelle, D. 1994. Bovine leukemia virus. The Retroviridae 3: 39-81.
16. Koenig, S., Woods, R.M., Brewah, Y.A., Newell, A.J., Jones, G.M., Boone, E., Adelsberger. J.W., Baseler, M.W., Robinson, S.M. and Jacobson, S. 1993. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-I infected patients with neurologic disease. J. Immunol. 151: 3874-3883.
17. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227: 680-685.
18. Mager, A., Masengo, R., Mammerickx, M. and Letesson, J.J. 1994. T cell proliferative response to bovine leukaemia virus (BLV): identification of T cell epitopes on the major core protein (p24) in BLV-infected cattle with normal haematological values. J. Gen. Virol. 75: 2223-2231.
19. Menon, J.N. and Bretscher, P.A. 1996. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge. Ear. J. Immunol. 26: 243-249.
20. Niewiesk, S., Daenke, S., Parker, C.E., Taylor, G., Weber, J., Nightingale, S. and Bangham, C.R. 1995. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J. Virol. 69: 2649-2653.
21. Ohishi, K., Suzuki, H., Yamamoto, T., Maruyama, T., Miki, K.. Ikawa, Y., Numakunai, S., Okada, K., Ohshima, K. and Sugimoto, M. 1991. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity. J. Gen. Virol. 65: 1938-1945.
22. Ohishi, K., Suzuki, H., Yasutomi, Y., Onuma, M., Okada, K., Numakunai, S., Ohshima, K., Ikawa, Y. and Sugimoto, M., 1992. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus, their role in the suppression of BLV replication. Microbiol. Immunol. 36:1317-1323.
23. Onuma, M., Hodatsu, T., Yamamoto, S., Higashihara, M , Masu, S., Mikami, T. and Izawa, H. 1984. Protection by vaccination against bovine leukemia virus infection in sheep. Am. J. Vet. Res. 45: 1212-1215,
24. Parker, C.E., Daenke, S., Nightingale, S. and Bangham, C.R. 1992. Activated, HTLV-I-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 188: 628-636.
25. Parker, C.E., Nightingale,. S., Taylor, G.P., Weber. J. and Bangham, C.R. 1994. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J. Virol. 68: 2860-2868.
26. Pique, C., Connan, F., Levilain, J.P., Choppin, J. and Dokhelar, M.C. 1996. Among all human T-cell leukemia virus type I proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response. J. Virol. 70: 4919-4926.
27. Re, M.C., Furlini, G., Vignoli, M., Ramazzotti, E., Roderigo, G., De, R.V., Zauli, G., Lolli, S., Capitani, S. and La, P.M. 1995. Effect of antibody to HIV-I Tat protein on viral replication in vitro and progression of HIV-I disease in vivo. J. AIDS. Human Retrovirol. 10: 408-416.
28. Sagata, N., Yasunaga, T., Tsuzuku, K.J., Ohishi, K., Ogawa. Y. and Ikawa, Y. 1985. Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses. Proc. Nail. Acad. Sci. U.S.A. 82: 677-681.
29. Steinaa, L., Sorensen, A.M., Nielsen, J.O. and Hansen, J.E. 1994. Antibody to HIV-I Tat protein inhibits the replication of virus in culture. Arch. Virol. 139: 263-271.
30. Takahashi, H., Germain, R., Moss, B. and Berzofsky, J. 1990. An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type I induces CD4 class II-restricted help for itself. J. Exp. Med. 172: 571-576.
31. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67: 1707-1711.